Related Experiment Videos
A mouse model of uterine leiomyosarcoma
Katerina Politi1, Matthias Szabolcs, Peter Fisher
1Department of Genetics and Development, Columbia University, New York, New York, USA.
The American Journal of Pathology
|December 26, 2003
Summary
This study developed a novel Cre/loxP system for inducible oncogene expression in mice. This system successfully generated mouse models of uterine leiomyosarcomas and seminal vesicle hyperplasia, aiding cancer research.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- The Cre/loxP recombination system is a powerful tool for genetic manipulation in mice.
- Developing accurate mouse models for tumorigenesis is crucial for understanding cancer development and testing therapies.
Purpose of the Study:
- To establish a versatile Cre/loxP-based system for inducible and tissue-specific oncoprotein expression.
- To create novel mouse models of cancer by activating oncogenes in a controlled manner.
Main Methods:
- Utilized a binary transgenic system with Cre-producing and Cre-responding mice.
- Integrated dormant oncogenes (SV40 early region T antigens - SVER) into the beta-actin locus.
- Employed Cre-mediated recombination to excise loxP-flanked sequences, activating oncogene expression.
Main Results:
- Ubiquitous Cre-dependent SVER expression initiated during embryogenesis did not affect viability.
- Female mice developed massive uterine leiomyosarcomas by 3 months of age.
- Male mice exhibited enlarged seminal vesicles due to smooth muscle hyperplasia; both sexes showed gallbladder dilation.
Conclusions:
- The developed Cre/loxP system effectively models tumorigenesis driven by specific oncoproteins.
- This approach provides a valuable platform for studying cancer signaling pathways and developing therapeutic strategies.